Allergy Therapeutics plc (AGYTF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.74 Million | -14.37 Million | 8.39 Million | 12.01 Million | 5.6 Million | -3.8 Million |
| Net Income | -49.82 Million | -12.65 Million | 3.65 Million | 8.07 Million | 4.29 Million | -6.89 Million |
| Depreciation & Amortization | 4.22 Million | 4.16 Million | 4.13 Million | 3.91 Million | 2.09 Million | 2.02 Million |
| Deferred income taxes | -1.61 Million | -419 Thousand | -1.97 Million | -1.59 Million | -3000.00 | -288 Thousand |
| Stock-based compensation | 114 Thousand | 469 Thousand | 635 Thousand | 794 Thousand | 1.36 Million | 985 Thousand |
| Change in working capital | 4.66 Million | -6.34 Million | 1.57 Million | 589 Thousand | -2.24 Million | 211 Thousand |
| Other non-cash items | 13.7 Million | 412 Thousand | 374 Thousand | 238 Thousand | 98 Thousand | 166 Thousand |
| Investing Cash Flow | -5.79 Million | -3.19 Million | -2.63 Million | -2.5 Million | -3.35 Million | -2.5 Million |
| Investments in PPE | -5.71 Million | -3.27 Million | -2.56 Million | -2.54 Million | -3.09 Million | -2.18 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -159 Thousand | -179 Thousand | -194 Thousand | -228 Thousand | -405 Thousand | -367 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 82 Thousand | 257 Thousand | 117 Thousand | 266 Thousand | 151 Thousand | 48 Thousand |
| Financing Cash Flow | 28.9 Million | -2.63 Million | -2.03 Million | -110 Thousand | 9.54 Million | -294 Thousand |
| Debt repayment | -10.96 Million | -957 Thousand | -757 Thousand | -654 Thousand | -651 Thousand | -398 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.48 Million | 3000.00 | 4000.00 | 1000.00 | 10.6 Million | 2000.00 |
| Other Financing Activities | 33.37 Million | -1.68 Million | -1.28 Million | 543 Thousand | -404 Thousand | 102 Thousand |
| Accounts receivables | 3.1 Million | -4.24 Million | 2.14 Million | 3.69 Million | -1.86 Million | 3.3 Million |
| Accounts payables | 1.69 Million | -1.06 Million | 548 Thousand | -2.39 Million | 162 Thousand | -1.76 Million |
| Inventory | -142 Thousand | -586 Thousand | -1.11 Million | -706 Thousand | -543 Thousand | -1.33 Million |
| Other working capital | 4.81 Million | -444 Thousand | - | - | - | 1.54 Million |
| Cash at beginning of period | 20.51 Million | 40.27 Million | 36.96 Million | 27.44 Million | 15.53 Million | 22.12 Million |
| Cash at end of period | 14.84 Million | 20.51 Million | 40.27 Million | 36.96 Million | 27.44 Million | 15.53 Million |
| Capital Expenditure | -5.71 Million | -3.27 Million | -2.56 Million | -2.54 Million | -3.09 Million | -2.18 Million |
| Effect of forex changes on cash | -34 Thousand | 451 Thousand | -415 Thousand | 131 Thousand | 115 Thousand | 10 Thousand |
| Net cash flow / Change in cash | -5.67 Million | -19.75 Million | 3.31 Million | 9.52 Million | 11.9 Million | -6.58 Million |
| Free Cash Flow | -34.46 Million | -17.64 Million | 5.83 Million | 9.46 Million | 2.5 Million | -5.98 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.82 Million | -7.82 Million | -49.82 Million | -34.56 Million | -17.28 Million | -8.5 Million |
| Depreciation & Amortization | 1.05 Million | 1.05 Million | 4.22 Million | 2.12 Million | 844.5 Thousand | 2.1 Million |
| Deferred income taxes | -4.79 Million | - | -1.61 Million | 5.56 Million | - | -6.05 Million |
| Stock-based compensation | 175.5 Thousand | 175.5 Thousand | 114 Thousand | 44.5 Thousand | 44.5 Thousand | 12.5 Thousand |
| Change in working capital | -1.78 Million | -1.78 Million | 4.66 Million | 9.85 Million | 1.81 Million | -1.83 Million |
| Other non-cash items | 2.98 Million | 2.98 Million | 13.7 Million | -6.36 Million | 3.86 Million | 6.71 Million |
| Investing Cash Flow | -898 Thousand | -898 Thousand | -5.79 Million | -1.78 Million | -860 Thousand | -2.88 Million |
| Investments in PPE | -932.5 Thousand | -932.5 Thousand | -5.71 Million | -1.78 Million | -1.2 Million | -2.88 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -159 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 34.5 Thousand | 34.5 Thousand | 82 Thousand | 347 Thousand | 347 Thousand | -306 Thousand |
| Financing Cash Flow | 5.59 Million | 5.59 Million | 28.9 Million | 24.87 Million | 11.44 Million | 5.03 Million |
| Debt repayment | -26.33 Million | - | -10.96 Million | -35.57 Million | - | -533 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 39.73 Million | - | 6.48 Million | 1000.00 | - | 6.48 Million |
| Other Financing Activities | 5.59 Million | 5.59 Million | 33.37 Million | -10 Million | 11.44 Million | 2.44 Million |
| Accounts receivables | -1.65 Million | -1.65 Million | 3.1 Million | 4.42 Million | 2.21 Million | -1.04 Million |
| Accounts payables | 3.17 Million | - | 1.69 Million | 6.22 Million | - | -1.4 Million |
| Inventory | -127.5 Thousand | -127.5 Thousand | -142 Thousand | -794 Thousand | -397 Thousand | 611 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 14.84 Million | - | 20.51 Million | 15.19 Million | 15.19 Million | 20.51 Million |
| Cash at end of period | 13.52 Million | -661.5 Thousand | 14.84 Million | 14.84 Million | 15.02 Million | 15.19 Million |
| Capital Expenditure | -932.5 Thousand | -932.5 Thousand | -5.71 Million | -1.78 Million | -1.2 Million | -2.88 Million |
| Effect of forex changes on cash | 31.5 Thousand | 31.5 Thousand | -34 Thousand | -50.5 Thousand | -50.5 Thousand | 51.5 Thousand |
| Net cash flow / Change in cash | -1.32 Million | -661.5 Thousand | -5.67 Million | -352 Thousand | -176 Thousand | -5.31 Million |
| Free Cash Flow | -6.31 Million | -6.31 Million | -34.46 Million | -25.13 Million | -11.92 Million | -10.45 Million |
CLN
ENTRINT
JETAIRWAYS
2388
DGE
GUER